Kala Pharmaceuticals Inc

NASDAQ:KALA  
7.41
-0.32 (-4.20%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)398.07M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.39 Million
Adjusted EPS-$0.47
See more estimates
10-Day MA$8.31
50-Day MA$7.92
200-Day MA$9.00
See more pivots

Kala Pharmaceuticals, Inc. Stock, NASDAQ:KALA

490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472
United States of America
Phone: +1.781.996.5252
Number of Employees: 136

Description

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.